Glycosmedia Weekly Diabetes News Update
View this email in your browser

Platinum Sponsors:

Gold Sponsors:


 
Novo Nordisk

Silver Sponsors:

Desang Diabetes Services

Glycosmedia Weekly Diabetes News - 03/18/2016

Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes

Overnight insulin requirements were significantly more variable than daytime and total daily amounts. This may explain why some people with type 1 diabetes report frustrating variability in morning glycemia (Diabetes Care)


Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin

More patients treated with canagliflozin experienced reductions in both HbA1c and body weight compared with glimepiride for up to 104 weeks. Canagliflozin was generally well tolerated in patients with T2DM when used in combination with metformin (Diabetes Therapy)


Engineering the gut for insulin replacement to treat diabetes

The burgeoning diabetes population and promising advances in this field warrant continued investments and efforts to explore the utility of engineered gut cells in the treatment of diabetes (Journal of Diabetes Investigation)


Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion

Although the success of GLP-1 analogs/mimetics in the treatment of type 2 diabetes and the correlation of strongly elevated postprandial GLP-1 levels after Roux-Y gastric bypass surgery strongly suggests benefits of recruiting endogenous GLP-1 reserves as a not yet exploited treatment alternative, the situation for GIP is less clear (Journal of Diabetes Investigation)


The effect of frailty should be considered in the management plan of older people with Type 2 diabetes

In frail older people, particularly in those with chronic wasting diseases and significant weight loss, blood glucose levels tend to normalize with increased risk of hypoglycemia. Recurrent hypoglycemia in frail older people with diabetes is a marker of vulnerability and hypoglycemic medication review or even complete withdrawal is appropriate in this group of patients (Future Science)


Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery

Based on the effect of ileal transposition, we can conclude that the contribution of the distal small intestine to the metabolic benefits of bariatric/metabolic surgery is quite considerable (Journal of Diabetes Investigation)


Share
Tweet
Forward
+1
Share

Advertisers:

13th Global Diabetes Conference & Medicare Expo

 

Please visit the Glycosmedia website for more features and information, including:

Journal Watch
Comment on recently published papers written by the medical editors of Glycosmedia.

Diabetes Updates
Updates written by Professor Steve Bain (Diabetologist) and Dr. Mark Freeman (Diabetologist).

Book and Product Reviews
A selection of book and product reviews written by the contributing editors of Glycosmedia.
Our sponsors have kindly provided unrestricted educational grants for the running of Glycosmedia. None of these companies have any input to, or editorial control over content.
 

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

 

Glycosmedia complies with the HONcode standard for trustworthy health information: verify here.


Copyright © 2016 Glycosmedia Partnership

Our mailing address is:
Glycosmedia Partnership
Institute of Life Science, College of Medicine
Swansea University
Swansea, SA2 8PP
United Kingdom

Add us to your address book


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by MailChimp